The insider sales are routine and non-informative at this scale. Monitor for any material corporate events (pipeline data, partnership, financing) that could drive the stock, but this cluster alone provides no actionable signal. The historical underperformance of prior STOK reports suggests caution in over-interpreting any single filing.
Price Chart
Executive Summary
Two Stoke Therapeutics insiders — a director and the general counsel — executed open-market sales totaling $469K on August 18, 2026, following the exercise of stock options on August 14. The sales represent ~0.02% of the $2.1B market cap, a trivial amount that does not signal material bearish conviction. The option exercises (non-cash) and same-day open-market sales are consistent with routine tax-covering or liquidity-driven transactions, not informed selling. The historical calibration shows past reports on STOK have underperformed (avg T+20 alpha -7.44%, 25% win rate), and the score-6 segment has a net negative payoff (μ_w +13.4% vs μ_l -16.9%, p_obs 53%). Given the trivial proportionality and weak historical signal, this cluster is neutral.
Key Financial Metrics
Key Facts
- Director Kaye sold 11,930 shares at $32.01 for $382K on Aug 18, 2026
- General Counsel Allan sold 2,716 shares at $32.01 for $87K on Aug 18, 2026
- Both insiders exercised stock options (non-cash) on Aug 14, 2026 before selling
- Total open-market sales = $469K, representing ~0.02% of $2.1B market cap
- Sales are trivial relative to market cap and consistent with liquidity/vesting-driven activity
Financial Impact
Total insider sales of $469K, ~0.02% of market cap — immaterial
Risk Factors
- Insider sales could accelerate if insiders hold more unexercised options
- No material bearish signal from this cluster — risk of false negative if ignoring other negative catalysts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-STOK-1787099375451 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $33.03 $28.93 | ▼ −12.41% | ▼ −10.46% | $25.96 (−21.40%) |
Aug 3, 2026 8w ago | 8-K | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.96 (+18.03%) |
Aug 3, 2026 8w ago | 424B5 | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.96 (+18.03%) |
Jun 30, 2026 13w ago | 8-K | $32.72 $29.31 | ▼ −10.42% | ▼ −9.39% | $25.96 (−20.66%) |
May 7, 2026 21w ago | 8-K | $32.89 $30.01 | ▼ −8.76% | ▼ −8.78% | $25.96 (−21.07%) |
Apr 22, 2026 23w ago | DEFA14A | $34.93 $30.30 | ▼ −13.27% | ▼ −17.90% | $25.96 (−25.68%) |
Apr 7, 2026 25w ago | 8-K | $34.87 $32.96 | ▼ −5.48% | ▼ −14.02% | $25.96 (−25.55%) |
Mar 13, 2026 29w ago | Insider Cluster | $33.19 $35.05 | ▼ −5.60% | ▼ −2.02% | $25.96 (+21.78%) |
Mar 10, 2026 29w ago | Insider Cluster | $38.35 $34.87 | ▼ −9.07% | ▼ −8.92% | $25.96 (−32.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access